CONTEXT: Formalin-fixed paraffin-embedded (FFPE) tissue is a standard for specimen preservation, and as such FFPE tissue banks are an untapped resource of histologically-characterized specimens for retrospective biomarker investigation for pancreatic disease. OBJECTIVES: We use liquid chromatography coupled with tandem mass spectrometry (LC-MS/MS) to compare FFPE specimens from three different diseases of the exocrine pancreas. DESIGN: We investigated the proteomic profile of FFPE pancreatic tissue from 9 archived specimens that were histologically classified as: autoimmune pancreatitis (n=3), chronic pancreatitis (n=3), and pancreatic cancer (n=3), using LC-MS/MS. SETTING: This is a proteomic analysis experiment of FFPE pancreatic tissue in an academic center. PATIENTS: FFPE tissue specimens were provided by Dana-Farber/Harvard Cancer Center (Boston, MA, USA). INTERVENTIONS: FFPE tissue specimens were collected via routine surgical resection procedures. MAIN OUTCOME MEASURES: We compared proteins identified from chronic pancreatitis, autoimmune pancreatitis, and pancreatic cancer FFPE pancreatic tissue. RESULTS: We identified 386 non-redundant proteins from 9 specimens. Following our filtering criteria, 73, 29, and 53 proteins were identified exclusively in autoimmune pancreatitis, chronic pancreatitis, and pancreatic cancer specimens, respectively. CONCLUSIONS: We report that differentially-expressed proteins can be identified among FFPE tissues specimens originating from individuals with different histological diagnoses. These proteins merit further confirmation with a greater number of specimens and orthogonal validation, such as immunohistochemistry. The mass spectrometry-based methodology used herein has the potential to enhance diagnostic biomarker and therapeutic target discovery, further advancing pancreatic research.
CONTEXT: Formalin-fixed paraffin-embedded (FFPE) tissue is a standard for specimen preservation, and as such FFPE tissue banks are an untapped resource of histologically-characterized specimens for retrospective biomarker investigation for pancreatic disease. OBJECTIVES: We use liquid chromatography coupled with tandem mass spectrometry (LC-MS/MS) to compare FFPE specimens from three different diseases of the exocrine pancreas. DESIGN: We investigated the proteomic profile of FFPE pancreatic tissue from 9 archived specimens that were histologically classified as: autoimmune pancreatitis (n=3), chronic pancreatitis (n=3), and pancreatic cancer (n=3), using LC-MS/MS. SETTING: This is a proteomic analysis experiment of FFPE pancreatic tissue in an academic center. PATIENTS: FFPE tissue specimens were provided by Dana-Farber/Harvard Cancer Center (Boston, MA, USA). INTERVENTIONS: FFPE tissue specimens were collected via routine surgical resection procedures. MAIN OUTCOME MEASURES: We compared proteins identified from chronic pancreatitis, autoimmune pancreatitis, and pancreatic cancer FFPE pancreatic tissue. RESULTS: We identified 386 non-redundant proteins from 9 specimens. Following our filtering criteria, 73, 29, and 53 proteins were identified exclusively in autoimmune pancreatitis, chronic pancreatitis, and pancreatic cancer specimens, respectively. CONCLUSIONS: We report that differentially-expressed proteins can be identified among FFPE tissues specimens originating from individuals with different histological diagnoses. These proteins merit further confirmation with a greater number of specimens and orthogonal validation, such as immunohistochemistry. The mass spectrometry-based methodology used herein has the potential to enhance diagnostic biomarker and therapeutic target discovery, further advancing pancreatic research.
Authors: Mehdi Benchekroun; Juli DeGraw; Jane Gao; Li Sun; Kristina von Boguslawsky; Arto Leminen; Leif C Andersson; Marja Heiskala Journal: Diagn Mol Pathol Date: 2004-06
Authors: Meng-Qiu Dong; John D Venable; Nora Au; Tao Xu; Sung Kyu Park; Daniel Cociorva; Jeffrey R Johnson; Andrew Dillin; John R Yates Journal: Science Date: 2007-08-03 Impact factor: 47.728
Authors: Ignat V Shilov; Sean L Seymour; Alpesh A Patel; Alex Loboda; Wilfred H Tang; Sean P Keating; Christie L Hunter; Lydia M Nuwaysir; Daniel A Schaeffer Journal: Mol Cell Proteomics Date: 2007-05-27 Impact factor: 5.911
Authors: Beth Ann Reimel; Sheng Pan; Damon H May; Scott A Shaffer; David R Goodlett; Martin W McIntosh; Lisa M Yerian; Mary P Bronner; Ru Chen; Teresa A Brentnall Journal: Curr Proteomics Date: 2009-04-01 Impact factor: 0.837
Authors: Lucía Trilla-Fuertes; Angelo Gámez-Pozo; María Isabel Lumbreras-Herrera; Rocío López-Vacas; Victoria Heredia-Soto; Ismael Ghanem; Elena López-Camacho; Andrea Zapater-Moros; María Miguel; Eva M Peña-Burgos; Elena Palacios; Marta De Uribe; Laura Guerra; Antje Dittmann; Marta Mendiola; Juan Ángel Fresno Vara; Jaime Feliu Journal: Cancers (Basel) Date: 2022-05-13 Impact factor: 6.575
Authors: John P Shapiro; Hannah M Komar; Baris Hancioglu; Lianbo Yu; Ming Jin; Yuko Ogata; Phil A Hart; Zobeida Cruz-Monserrate; Gregory B Lesinski; Darwin L Conwell Journal: Clin Transl Gastroenterol Date: 2017-04-13 Impact factor: 4.488
Authors: Siddharth Narayanan; Gopalakrishnan Loganathan; Maheswaran Dhanasekaran; William Tucker; Ankit Patel; Venugopal Subhashree; SriPrakash Mokshagundam; Michael G Hughes; Stuart K Williams; Appakalai N Balamurugan Journal: World J Transplant Date: 2017-04-24